Abstract
The choice of management strategy in patients with recent-onset AF does not affect clinical outcomes, but does influence the likelihood of progression to permanent AF, according to data from an international registry of patients with arrhythmias. Patients with AF usually receive antithrombotic treatment, and a strategy to control either rate (by keeping ventricular rate at a physiological level, while allowing continued atrial flutter) or rhythm (by restoration and maintenance of sinus rhythm) to manage recurrent arrhythmic episodes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
